Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$2.31M |
| 2 |
Accenture
ACN
|
+$530K |
| 3 |
Salesforce
CRM
|
+$475K |
| 4 |
Conagra Brands
CAG
|
+$462K |
| 5 |
Adobe
ADBE
|
+$258K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$2.28M |
| 2 |
CVS Health
CVS
|
+$1.07M |
| 3 |
Biogen
BIIB
|
+$1.06M |
| 4 |
TSMC
TSM
|
+$955K |
| 5 |
Oracle
ORCL
|
+$836K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.88% |
| 2 | Consumer Staples | 18.68% |
| 3 | Technology | 14.99% |
| 4 | Communication Services | 9.25% |
| 5 | Materials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$77.7B
| $2.48M | 1.79% |
100,843
+5,615
| +6% | +$145K |
2020 Q4
22 quarters
|
|
27
Walt Disney
DIS
$191B
| $2.44M | 1.77% |
25,385
+786
| +3% | +$80.1K |
2022 Q4
14 quarters
|
|
|
28
Conagra Brands
CAG
$6.91B
| $2.43M | 1.76% |
180,728
+33,089
| +22% | +$462K |
2021 Q3
19 quarters
|
|
29
Verizon
VZ
$186B
| $2.42M | 1.76% |
57,263
-7,735
| -12% | -$363K |
2019 Q4
26 quarters
|
|
30
United Parcel Service
UPS
$82.9B
| $2.4M | 1.74% |
22,316
| – | – |
2025 Q3
3 quarters
|
|
31
Becton Dickinson
BDX
$52.2B
| $2.31M | 1.67% |
15,238
+1,029
| +7% | +$154K |
2020 Q1
25 quarters
|
|
32
UnitedHealth
UNH
$360B
| $2.25M | 1.63% |
5,405
-2,000
| -27% | -$741K |
2025 Q3
3 quarters
|
|
33
Diageo
DEO
$52.9B
| $2.21M | 1.6% |
27,492
-15
| -0.1% | -$1.21K |
2024 Q4
6 quarters
|
|
34
Constellation Brands
STZ
$22.2B
| $2.18M | 1.58% |
15,651
-3,144
| -17% | -$467K |
2020 Q4
22 quarters
|
|
|
35
Salesforce
CRM
$198B
| $2.14M | 1.55% |
13,658
+2,702
| +25% | +$475K |
2021 Q2
20 quarters
|
|
36
Equifax
EFX
$18.9B
| $1.99M | 1.44% |
12,541
-1,015
| -7% | -$173K |
2022 Q1
17 quarters
|
|
37
Akamai
AKAM
$12.6B
| $1.94M | 1.4% |
16,387
-6,438
| -28% | -$802K |
2025 Q2
4 quarters
|
|
38
Hershey
HSY
$34.3B
| $1.86M | 1.35% |
10,608
| – | – |
2025 Q1
5 quarters
|
|
|
39
Oracle
ORCL
$389B
| $1.68M | 1.22% |
11,496
-4,613
| -29% | -$836K |
2026 Q1
1 quarter
|
|
40
iShares Core S&P 500 ETF
IVV
$880B
| $1.19M | 0.86% |
1,589
+339
| +27% | +$247K |
2022 Q4
14 quarters
|
|
41
Medtronic
MDT
$121B
| $446K | 0.32% |
5,707
+2,039
| +56% | +$164K |
2025 Q1
5 quarters
|
|
|
42
T. Rowe Price
TROW
$21.5B
| $410K | 0.3% |
3,610
-22,292
| -86% | -$2.28M |
2022 Q1
17 quarters
|
|
43
Air Products & Chemicals
APD
$66.7B
| $383K | 0.28% |
1,306
-33
| -2% | -$9.6K |
2021 Q4
18 quarters
|
|
|
44
Accenture
ACN
$141B
| $380K | 0.28% |
+3,055
| New | +$530K |
2026 Q2
0 quarters
|
|
45
Thermo Fisher Scientific
TMO
$255B
| $376K | 0.27% |
750
+94
| +14% | +$45.1K |
2025 Q3
3 quarters
|
|
46
RTX Corp
RTX
$261B
| $367K | 0.27% |
1,935
-40
| -2% | -$7.34K |
2020 Q2
24 quarters
|
|
47
Alphabet (Google) Class C
GOOG
$4.12T
| $364K | 0.26% |
1,030
-97
| -9% | -$34.7K |
2020 Q4
22 quarters
|
|
48
ServiceNow
NOW
$147B
| $339K | 0.25% |
3,415
+38
| +1% | +$3.76K |
2026 Q1
1 quarter
|
|
49
Clorox
CLX
$10.5B
| $337K | 0.24% |
3,531
-24
| -0.7% | -$2.3K |
2026 Q1
1 quarter
|
|
50
Blackrock
BLK
$176B
| $330K | 0.24% |
343
-4
| -1% | -$4.14K |
2024 Q4
6 quarters
|
|
Similar funds
Mark Hillman's Q2 2026 Portfolio in Review
As of Q2 2026, Mark Hillman held 58 positions worth $138M, down 4.1% from $144M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mark Hillman withdrew a net $10.4M in Q2 2026, closing 4 positions and reducing 36 holdings. Its most notable exit was GE Aerospace, an estimated $364K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Mark Hillman opened a new position in Veeva Systems worth $2.49M.
- Mark Hillman's largest Q2 2026 buy was Veeva Systems: 14,008 shares worth $2.49M.
- Mark Hillman added most to Salesforce in Q2 2026, an estimated $475K increase.
- Mark Hillman's biggest Q2 2026 reduction was T. Rowe Price, cutting an estimated $2.28M.
- Mark Hillman fully exited GE Aerospace in Q2 2026, selling an estimated $364K.
- Mark Hillman's ten largest holdings make up 36% of its $138M portfolio in Q2 2026.
- Mark Hillman opened 2 new positions and closed 4 in Q2 2026.
- Mark Hillman's portfolio value fell 4.1% quarter-over-quarter to $138M.
Based on Hillman Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.